SLDB
Price
$6.86
Change
-$0.12 (-1.72%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
780.6M
40 days until earnings call
Intraday BUY SELL Signals
STTK
Price
$6.74
Change
-$0.10 (-1.46%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
645.34M
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SLDB vs STTK

SLDB vs STTK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SLDB vs. STTK commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLDB is a Hold and STTK is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
SLDB vs STTK: Fundamental Ratings
SLDB
STTK
OUTLOOK RATING
1..100
8641
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6438
P/E GROWTH RATING
1..100
3100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLDB's Valuation (25) in the Biotechnology industry is somewhat better than the same rating for STTK (64) in the null industry. This means that SLDB’s stock grew somewhat faster than STTK’s over the last 12 months.

SLDB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as STTK (100) in the null industry. This means that SLDB’s stock grew similarly to STTK’s over the last 12 months.

STTK's SMR Rating (97) in the null industry is in the same range as SLDB (98) in the Biotechnology industry. This means that STTK’s stock grew similarly to SLDB’s over the last 12 months.

STTK's Price Growth Rating (38) in the null industry is in the same range as SLDB (64) in the Biotechnology industry. This means that STTK’s stock grew similarly to SLDB’s over the last 12 months.

SLDB's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for STTK (100) in the null industry. This means that SLDB’s stock grew significantly faster than STTK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLDBSTTK
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (SLDB: $6.98 vs. STTK: $6.84)
Brand notoriety: SLDB and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLDB: 143% vs. STTK: 186%
Market capitalization -- SLDB: $780.6M vs. STTK: $645.34M
SLDB [@Biotechnology] is valued at $780.6M. STTK’s [@Biotechnology] market capitalization is $645.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLDB’s FA Score shows that 2 FA rating(s) are green while STTK’s FA Score has 0 green FA rating(s).

  • SLDB’s FA Score: 2 green, 3 red.
  • STTK’s FA Score: 0 green, 5 red.
According to our system of comparison, SLDB is a better buy in the long-term than STTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLDB’s TA Score shows that 5 TA indicator(s) are bullish while STTK’s TA Score has 4 bullish TA indicator(s).

  • SLDB’s TA Score: 5 bullish, 5 bearish.
  • STTK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SLDB is a better buy in the short-term than STTK.

Price Growth

SLDB (@Biotechnology) experienced а -6.68% price change this week, while STTK (@Biotechnology) price change was +8.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.69%. For the same industry, the average monthly price growth was -14.47%, and the average quarterly price growth was -1.83%.

Reported Earning Dates

SLDB is expected to report earnings on Nov 11, 2026.

STTK is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
SLDB
Daily Signal:
Gain/Loss:
STTK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIZZ29.690.49
+1.68%
National Beverage Corp
UNTY54.650.43
+0.79%
Unity Bancorp
MTZ213.660.04
+0.02%
MasTec
PRFX0.95N/A
-0.03%
PRF Technologies Ltd.
NIPG11.15-0.21
-1.85%
NIP Group Inc.

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-3.46%
EDIT - SLDB
56%
Loosely correlated
-1.95%
RCKT - SLDB
53%
Loosely correlated
-1.52%
FDMT - SLDB
53%
Loosely correlated
-3.28%
CRBU - SLDB
52%
Loosely correlated
-3.94%
BEAM - SLDB
51%
Loosely correlated
-0.25%
More

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with GHRS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then GHRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
+0.29%
GHRS - STTK
39%
Loosely correlated
-2.64%
VRTX - STTK
36%
Loosely correlated
-3.07%
SLDB - STTK
36%
Loosely correlated
-3.46%
CELC - STTK
35%
Loosely correlated
-5.52%
WHWK - STTK
35%
Loosely correlated
N/A
More